Aidapak Recalls Docusate Sodium Capsules Due to Potential Label Mixup
Aidapak Services, LLC is recalling 4,318 Docusate Sodium capsules because they may be mislabeled as other medications. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a label mixup where a laxative could be mistaken for other medications, posing a risk of harm if the wrong drug is administered, though no specific injuries are reported in the text.
Plain-English summary
Aidapak Services, LLC is recalling 4,318 capsules of Docusate Sodium, 250 mg, Over The Counter, NDC 00904789159. The recall was initiated because the product may be potentially mislabeled as Atropine Sulfate/Diphenoxylate HCl, Valsartan, or Pantoprazole Sodium DR.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The affected lots include specific pedigree codes and expiration dates ranging from May 13, 2014, to June 25, 2014.
Consumers should check their medication for the NDC 00904789159 and the specific pedigree codes listed in the recall notice. If the product matches the description, consumers should stop using it and contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- DOCUSATE SODIUM, Capsule, 250 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904789159
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-The-Counter
- Hazard
- Affected units
- 4,318
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- DOCUSATE SODIUM
- Capsule
- 250 mg has the following codes Pedigree: AD68028_1
- EXP: 5/28/2014
- Pedigree: AD68022_1
- Pedigree: AD37072_1
- EXP: 5/13/2014
- Pedigree: AD37072_4
- Pedigree: AD56924_1
- EXP: 5/21/2014
- Pedigree: W003671
- EXP: 6/25/2014
- Pedigree: W002920
- EXP: 6/10/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Docusate Sodium Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Docusate Sodium Capsules Due to Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Docusate Calcium Capsules Due to Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Dutasteride Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateSodium Chloride Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Levothyroxine Sodium Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29